$165.05
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Balchem Corp. markets specialty performance ingredients and products. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Country

US

CEO

Mr. Theodore Harris

IPO date

1986

Employees

1,368

ISIN

US0576652004

Key stats

Open

$165.73

Volume

165.09K

Market cap

$5.31B

Prev. close

$165.34

Impl / hst vl

-

Open interest

$0.00

$164.30

Day’s Range

$167.98

$152.58

52W Range

$183.01

Valuation

38
Valuation score
Overvalued
P/E
34.34
P/S
5.13
P/B
4.22
Current ratio
2.55
Debt / Equity
0.08
ROE
12.38%
Gross margin
37.34%
Income growth
2.70%
FCF growth
-33.79

Jan

20

Dividends

The last payment date was Jan 20, 2026

Div. per Share

$0.96

Div. Yield

0.58%

Payout Ratio

18.27%

Div. Growth YoY

10.34%

Analysts estimates

Consensus rating
Buy

The average rating from top 5 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$204.77
The top 6 analysts forecasts that 12-month price may increase by 24.06%, with a low of $165.64 and a high of $245.70
$165.64
Low
$204.77
Avg
$245.70
High
Current price

Earnings

Q1 ‘26 revenue
$270.71M
Q1 ‘26 net income
$40.29M
Revenue
Net income
Previous EPS
$1.31
Estimate EPS
$1.36
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply